And a couple of good op-eds from PhRMA and BIO leaders
And a fascinating look at how 'innovation' can go awry
And a brief history of Lilly's copay coupon for Mounjaro
And GoFundMe continues to bring clarity to the true holes in the American safety net
And it's PBM Week in Washington
And thanks to the ASPC, whose members are ready to go to the mattresses on UM
But my conversation with TheracosBio was fun. Like really fun.
And I'm looking forward to diving into TheracosBio tomorrow
Plus an interesting nugget buried in Novartis' earnings call
And Lilly's data makes Alzheimer's that much more interesting
And a quarterly reminder that UnitedHealth is making money hand-over-fist
And HHS defines exactly who will benefit from the Part D OOP cap
